WO2006071897A3 - Treatment of macular degeneration with lonidamine - Google Patents
Treatment of macular degeneration with lonidamine Download PDFInfo
- Publication number
- WO2006071897A3 WO2006071897A3 PCT/US2005/047145 US2005047145W WO2006071897A3 WO 2006071897 A3 WO2006071897 A3 WO 2006071897A3 US 2005047145 W US2005047145 W US 2005047145W WO 2006071897 A3 WO2006071897 A3 WO 2006071897A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lonidamine
- macular degeneration
- treatment
- administering
- treated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Macular degeneration is treated by administering a therapeutically effective amount of lonidamine or a lonidamine analog.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63905504P | 2004-12-23 | 2004-12-23 | |
| US60/639,055 | 2004-12-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2006071897A2 WO2006071897A2 (en) | 2006-07-06 |
| WO2006071897A3 true WO2006071897A3 (en) | 2006-10-19 |
Family
ID=36615495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2005/047145 Ceased WO2006071897A2 (en) | 2004-12-23 | 2005-12-22 | Treatment of macular degeneration with lonidamine |
Country Status (2)
| Country | Link |
|---|---|
| TW (1) | TW200633705A (en) |
| WO (1) | WO2006071897A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008001811A1 (en) * | 2008-05-15 | 2009-11-19 | Beiersdorf Ag | Cosmetic preparations for reducing sweat odor with ABCC modulators |
| KR102377008B1 (en) * | 2019-07-01 | 2022-03-21 | 서울대학교산학협력단 | Pharmaceutical composition for preventing or treating angiogenesis relating ocular diseases comprising inhibitors of MCT expression or activity |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6482802B1 (en) * | 1998-05-11 | 2002-11-19 | Endowment For Research In Human Biology, Inc. | Use of neomycin for treating angiogenesis-related diseases |
-
2005
- 2005-12-22 WO PCT/US2005/047145 patent/WO2006071897A2/en not_active Ceased
- 2005-12-22 TW TW094145759A patent/TW200633705A/en unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6482802B1 (en) * | 1998-05-11 | 2002-11-19 | Endowment For Research In Human Biology, Inc. | Use of neomycin for treating angiogenesis-related diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006071897A2 (en) | 2006-07-06 |
| TW200633705A (en) | 2006-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005102335A3 (en) | Methods of treating sleep disorders | |
| WO2007087468A3 (en) | Adiponectin for treatment of various disorders | |
| WO2006102374A3 (en) | Bioactive wide-weave mesh | |
| WO2007098089A3 (en) | Treatment of hyperproliferative diseases with methotrexate n-oxide and analogs | |
| WO2005096990A3 (en) | Novel modification of medical prostheses | |
| WO2008000513A3 (en) | Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction | |
| GB0404693D0 (en) | Pharmaceutical preparations for the treatment of ocular surface and other disorders | |
| WO2007136759A3 (en) | Method for the treatment and prevention of ocular disorders | |
| WO2007098091A3 (en) | Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs | |
| WO2006119958A3 (en) | Use of flibanserin in the treatment of chronic pain | |
| WO2005037323A3 (en) | Use of gro to treat or prevent inflammation | |
| WO2007095389A3 (en) | Treatment of hyperproliferative diseases with camptothecine n-oxide and analogs | |
| WO2008090287A3 (en) | Use of at least one botulism neurotoxin for treating the pain induced by therapeutic treatments for the aids virus | |
| WO2005107872A3 (en) | Treating respiratory diseases with gycopyrrolate and analogues | |
| WO2005118609A3 (en) | Small molecule stimulators of neuronal growth | |
| WO2006113978A3 (en) | Insulins combinations | |
| WO2006074265A3 (en) | Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders | |
| WO2007130501A3 (en) | Combination therapy for treatment of cancer | |
| WO2006002096A3 (en) | Low doses of l-citrulline for treating diseases | |
| WO2007056301A3 (en) | Antibody therapy for treatment of diseases associated with gluten intolerance | |
| GB0521716D0 (en) | Modulation of 11beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases | |
| WO2006071897A3 (en) | Treatment of macular degeneration with lonidamine | |
| TW200724146A (en) | Use of LGG in the manufacture of a medicament for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant | |
| AU2003240545A1 (en) | Use of ramoplanin to treat diseases associated with the use of antibiotics | |
| AU2003289652A1 (en) | The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 05855663 Country of ref document: EP Kind code of ref document: A2 |